Home › Research › Risk factors
International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause
Nick Panay, Anna J. Fenton, Haitham Hamoda, Timothy Hillard, Rakibul M. Islam, Hugo Pedder, Lorena Romero, Amanda J. Vincent et al.. Climacteric, 2025-11-02
Topic: Risk, prevention and care in population studies
Overall, 342 recommendations (285 supported by research data and 57 good practice points) and 40 key messages have been formulated. The overall aim of these recommendations and guidelines is to provide the blueprint for support and guidance to women on midlife health and menopause, given the latest available evidence.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Panay, N., Fenton, A. J., Hamoda, H., Hillard, T., Islam, R. M., Pedder, H., et al. (2025). International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause. Climacteric. https://doi.org/10.1080/13697137.2025.2585487
Vancouver
Panay N, Fenton AJ, Hamoda H, Hillard T, Islam RM, Pedder H, et al. International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause. Climacteric. 2025. doi:10.1080/13697137.2025.2585487. PMID: 41433054.
BibTeX
@article{panay2025-41433054,
author = {Panay, Nick and Fenton, Anna J. and Hamoda, Haitham and Hillard, Timothy and Islam, Rakibul M. and Pedder, Hugo and Romero, Lorena and Vincent, Amanda J. and others},
title = {{International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause}},
journal = {Climacteric},
year = {2025},
doi = {10.1080/13697137.2025.2585487},
pmid = {41433054},
url = {https://doi.org/10.1080/13697137.2025.2585487}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Overall, 342 recommendations (285 supported by research data and 57 good practice points) and 40 key messages have been formulated.
- The overall aim of these recommendations and guidelines is to provide the blueprint for support and guidance to women on midlife health and menopause, given the latest available evidence.
Why it matters
These are recommendations and key messages on women's midlife health and menopause based on available evidence. The text does not address treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designsystematic review
- Evidence strengthHigh
How this study scored 65/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 62 of the 96 points we could judge it on, which is 65 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Climacteric) |
| Journal's citation record | 1 / 4 | Climacteric: journal h-index 104 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | A review of other studies — randomisation is not credited here |
| Times cited | 4 / 7 | Cited 52 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 17.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 5 / 6 | Cited 31.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 52 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author (IMS Publication Steering Committee) and The IMS Recommendations Writing Group holds only 1 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 2 / 3 | Imperial College London: institution h-index 1,744 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41433054) |
| Free to read | 2 / 2 | Free to read |
| Points | 62 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 62 of the 96 points we could judge it on is 65 out of 100. |
| Total | 65 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Risk factors
Also in Risk factors
356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.